BELZANT Trademark

Trademark Overview

On Wednesday, June 12, 2019, a trademark application was filed for BELZANT with the United States Patent and Trademark Office. The USPTO has given the BELZANT trademark a serial number of 88469965. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Johnson & Johnson. The BELZANT trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of cardiovascular and pulmonary diseases and oncologic diseases
belzant

General Information

Serial Number88469965
Word MarkBELZANT
Filing DateWednesday, June 12, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of cardiovascular and pulmonary diseases and oncologic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU EXTENSION 5 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 5 FILED
Thursday, June 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 14, 2022TEAS EXTENSION RECEIVED
Thursday, January 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 4 FILED
Tuesday, January 25, 2022TEAS EXTENSION RECEIVED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU EXTENSION 3 GRANTED
Thursday, August 5, 2021SOU EXTENSION 3 FILED
Thursday, August 5, 2021TEAS EXTENSION RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021SOU EXTENSION 2 GRANTED
Monday, February 8, 2021SOU EXTENSION 2 FILED
Monday, February 8, 2021TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2020SOU EXTENSION 1 GRANTED
Monday, August 10, 2020SOU EXTENSION 1 FILED
Monday, August 10, 2020TEAS EXTENSION RECEIVED
Tuesday, February 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, December 29, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, November 26, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, November 21, 2019ASSIGNED TO PETITION STAFF
Monday, October 7, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 4, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 20, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 12, 2019ASSIGNED TO EXAMINER
Tuesday, June 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 15, 2019NEW APPLICATION ENTERED

Related Keywords

belzant diseases pulmonary oncologic cardiovascular treatment pharmaceutical preparations prevention human